• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA (CVD) EPIC SUPRA VALVE W/FLEXFIT; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA (CVD) EPIC SUPRA VALVE W/FLEXFIT; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number ESP100-19
Device Problem Torn Material (3024)
Patient Problem Aortic Regurgitation (1716)
Event Date 08/01/2017
Event Type  Injury  
Event Description
On (b)(6) 2016, a double valve replacement was performed and this 19 mm epic supra valve was implanted in the aortic position and a 29 mm epic valve was implanted supra-annularly in the mitral position using non-everting mattress sutures and pledgets.On an unknown date, aortic regurgitation was observed at a routine follow-up.On (b)(6) 2017, the 19 mm epic supra valve (aortic) was explanted and a 19 mm magna ease valve was implanted.Ex vivo,a non-coronary cusp of the 19 mm epic supra valve was reported to contain an oval-shaped perforation.Per report, the surgeon suspected the perforated cusp either was due to the patient's history of infection or occurred at implant.The 29 mm epic mitral valve remains implanted.
 
Manufacturer Narrative
The results of this investigation concluded the returned 19mm epic supra valve contained acute and chronic endocarditis.The base of cusp 1 contained a vegetation with acute and chronic inflammation, and disruption of the cusp architecture.Cusps 1 and 3 contained tears and degenerative changes.There was thin layer of fibrous pannus on the inflow surface of cusp 3.Special stains were negative for organisms and there was no significant calcifications were present in the valve.A review of the device history record showed the device met specifications prior to leaving abbott manufacturing facilities.There was no evidence found to suggest the cause of the endocarditis, tears, or pannus were due to an intrinsic defect in the valve, as supported by review of the valve's device history record and the analysis performed.The cause of the reported event remains unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC SUPRA VALVE W/FLEXFIT
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA (CVD)
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 1897- 4050
CS  1897-4050
Manufacturer (Section G)
ST. JUDE MEDICAL, COSTA RICA LTDA (CVD)
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 1897- 4050
CS   1897-4050
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key6800246
MDR Text Key82897172
Report Number3008452825-2017-00179
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2019
Device Model NumberESP100-19
Device Catalogue NumberESP100-19
Device Lot Number5172491
Other Device ID Number05414734027458
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/25/2017
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/01/2017
Initial Date FDA Received08/17/2017
Supplement Dates Manufacturer Received08/25/2017
09/15/2017
Supplement Dates FDA Received10/05/2017
10/09/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-